SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Preferred Stock Liabilities (2021 - 2022)

SeaStar Medical Holding's (ICU) quarterly Preferred Stock Liabilities came in at $106.8 million in Q3 2022, up 1.21% YoY from $105.6 million in Q3 2021, and up 1.21% on a QoQ basis from $105.6 million in Q2 2022.

SeaStar Medical Holding (ICU) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends

SeaStar Medical Holding (ICU) has 2 years of Preferred Stock Liabilities data on file, last reported at $106.8 million in Q3 2022.

  • Quarterly Preferred Stock Liabilities rose 1.21% year-over-year to $106.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $106.8 million (up 1.21% YoY) and the FY2021 annual result came in at $105.6 million, changed N/A from the prior year.
  • Preferred Stock Liabilities advanced to $106.8 million in Q3 2022, from $105.6 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $106.8 million in Q3 2022 to a low of $16.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2022 106.85 Mn
Jun 30, 2022 105.57 Mn
Mar 31, 2022 105.57 Mn
Dec 31, 2021 105.57 Mn
Sep 30, 2021 105.57 Mn
Jun 30, 2021 105.57 Mn
Mar 31, 2021 15.96 Mn